- Review your activity description in the Trade Register before September
- Strengthening of the Oss pharmaceutical cluster through planned collaboration between Pivot Park and Aspen Oss
- Strengthening of the Oss pharmaceutical cluster through planned collaboration between Pivot Park and Aspen Oss
- Aleksandr Garin Receives €1,000 Pedro Hermkens Stipend
- A celebration of community at Pivot Park’s Summer Festival
- Delegation from Baden-Württemberg visits Pivot Park
- Surviving the Dutch: Helping Internationals Feel at Home @Pivot Park
- Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
- Advipro is now Normec Advipro
- Pivot Park and QuestPair: Smart labs, strong starts
- Supporting talent through the Pedro Hermkens stipend
- Capsule Photonics wins Venture Challenge Winter 2024 – 2025
- SOTIO Biotech Expands Collaboration with Synaffix for Bispecific ADC Development
- Strategic Partnership between Cell4Pharma and Bio-Connect
- Citryll demonstrates a broader therapeutic potential for CIT-013 in the treatment of inflammatory disorders